A5084680215- Angiogenesis and VEGF in Cancer
- Endometrial and Cervical Cancer Treatments
- SARS-CoV-2 and COVID-19 Research
- Pharmaceutical studies and practices
- Transplantation: Methods and Outcomes
- COVID-19 Clinical Research Studies
- Vascular Anomalies and Treatments
- Ovarian cancer diagnosis and treatment
- Psychosomatic Disorders and Their Treatments
- Neutropenia and Cancer Infections
- Hepatitis C virus research
- Lymphoma Diagnosis and Treatment
- Sepsis Diagnosis and Treatment
- Public Health and Environmental Issues
- Pharmacology and Obesity Treatment
- Chronic Lymphocytic Leukemia Research
- Pneumocystis jirovecii pneumonia detection and treatment
- Hematopoietic Stem Cell Transplantation
- Poisoning and overdose treatments
- Treatment of Major Depression
- Renal Diseases and Glomerulopathies
- Mental Health Treatment and Access
- COVID-19 epidemiological studies
- Pharmacogenetics and Drug Metabolism
Hospital de Nens de Barcelona
2021
Vall d'Hebron Hospital Universitari
2020-2021
Vall d'Hebron Institut de Recerca
2021
Hospital Clínic de Barcelona
2013
Universidad Autónoma de Madrid
2008
Eli Lilly (Spain)
2008
Hospital Universitario Miguel Servet
2008
To investigate the relationship between characteristics of somatic symptoms and depression severity, quality life (QOL), health resources utilization in patients with major depressive disorder (MDD) primary care setting.This cross-sectional, nationwide epidemiologic study, carried out 1150 DSM-IV-defined MDD, evaluated by means Standardized Polyvalent Psychiatric Interview. Depression severity QOL were Zung Self-Rating Scale (SDS) Physical Mental Component Summaries Medical Outcomes Study...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective therapy resulting in increased definitive cure rates or extended disease-free survival various malignant and nonmalignant hematologic diseases. However, because of the high risk severe complications this therapy, up to 50% patients may require being admitted intensive care unit (ICU) manage life-threatening conditions. We aimed evaluate in-hospital mortality allo-HSCT recipients ICU identify those variables...